The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53

The E6 protein encoded by the oncogenic human papillomavirus types 16 and 18 is one of two viral products expressed in HPV-associated cancers. E6 is an oncoprotein which cooperates with E7 to immortalize primary human keratinocytes. Insight into the mechanism by which E6 functions in oncogenesis is provided by the observation that the E6 protein encoded by HPV-16 and HPV-18 can complex the wild-type p53 protein in vitro. Wild-type p53 gene has tumor suppressor properties, and is a target for several of the oncoproteins encoded by DNA tumor viruses. In this study we demonstrate that the E6 proteins of the oncogenic HPVs that bind p53 stimulate the degradation of p53. The E6-promoted degradation of p53 is ATP dependent and involves the ubiquitin-dependent protease system. Selective degradation of cellular proteins such as p53 with negative regulatory functions provides a novel mechanism of action for dominant-acting oncoproteins.

[1]  A Ciechanover,et al.  How are substrates recognized by the ubiquitin-mediated proteolytic system? , 1989, Trends in biochemical sciences.

[2]  E. Villiers Heterogeneity of the human papillomavirus group. , 1989 .

[3]  Y. Nakamura,et al.  Allelotype of colorectal carcinomas. , 1989, Science.

[4]  D. Givol,et al.  Human p53 cellular tumor antigen: cDNA sequence and expression in COS cells. , 1985, The EMBO journal.

[5]  M. Ewen,et al.  An N-Terminal transformation-governing sequence of SV40 large T antigen contributes to the binding of both p110 Rb and a second cellular protein, p120 , 1989, Cell.

[6]  Erica S. Johnson,et al.  Cis-trans recognition and subunit-specific degradation of short-lived proteins , 1990, Nature.

[7]  Wolfgang Mayer,et al.  Structure and transcription of human papillomavirus sequences in cervical carcinoma cells , 1985, Nature.

[8]  Wen-Hwa Lee,et al.  SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene , 1988, Cell.

[9]  D. Pim,et al.  Analysis of human p53 proteins and mRNA levels in normal and transformed cells. , 1986, European journal of biochemistry.

[10]  R. Schlegel,et al.  Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. , 1985, The American journal of pathology.

[11]  H. Ruley Transforming collaborations between ras and nuclear oncogenes. , 1990, Cancer cells.

[12]  D. Lowy,et al.  HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes. , 1989, The EMBO journal.

[13]  M. Oren,et al.  Wild-type p53 can inhibit oncogene-mediated focus formation. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[14]  A. Levine,et al.  Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation , 1989, Journal of virology.

[15]  K. Yoshiike,et al.  Transformation of rat 3Y1 cells by human papillomavirus type‐18 DNA , 1988, International journal of cancer.

[16]  S. Benchimol,et al.  Immortalization of rat embryo fibroblasts by the cellular p53 oncogene. , 1988, Oncogene.

[17]  K. Münger,et al.  Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. , 1989, The EMBO journal.

[18]  D. Pim,et al.  Comparison of the in vitro transforming activities of human papillomavirus types. , 1988, The EMBO journal.

[19]  A. Levine,et al.  Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life , 1988, Molecular and cellular biology.

[20]  H. Hausen,et al.  The Role of Papillomaviruses in Human Anogenital Cancer , 1987 .

[21]  S. Grossman,et al.  Identification of human papillomavirus type 18 transforming genes in immortalized and primary cells , 1989, Journal of virology.

[22]  D. Lowy,et al.  The E7 open reading frame of human papillomavirus type 16 encodes a transforming gene. , 1988, Oncogene research.

[23]  A. Levine,et al.  The p53 proto-oncogene can act as a suppressor of transformation , 1989, Cell.

[24]  A. Levine,et al.  Characterization of a 54K Dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells , 1979, Cell.

[25]  P. Gruss,et al.  Participation of p53 cellular tumour antigen in transformation of normal embryonic cells , 1984, Nature.

[26]  S. Fields,et al.  Presence of a potent transcription activating sequence in the p53 protein. , 1990, Science.

[27]  J. Jenkins,et al.  Cellular immortalization by a cDNA clone encoding the transformation-associated phosphoprotein p53 , 1984, Nature.

[28]  T. Smith,et al.  Prediction of similar transforming regions in simian virus 40 large T, adenovirus E1A, and myc oncoproteins , 1988, Journal of virology.

[29]  A. Haas,et al.  The immunochemical detection and quantitation of intracellular ubiquitin-protein conjugates. , 1985, The Journal of biological chemistry.

[30]  K. Münger,et al.  The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A , 1988, Cell.

[31]  J. Minna,et al.  p53: a frequent target for genetic abnormalities in lung cancer. , 1989, Science.

[32]  A. Bernstein,et al.  Rearrangements of the cellular p53 gene in erythroleukaemic cells transformed by Friend virus , 1985, Nature.

[33]  A. Levine,et al.  Two distinct mechanisms regulate the levels of a cellular tumor antigen, p53 , 1983, Molecular and cellular biology.

[34]  Stephen H. Friend,et al.  Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product , 1988, Nature.

[35]  B. Vogelstein,et al.  Suppression of human colorectal carcinoma cell growth by wild-type p53. , 1990, Science.

[36]  A. Levine,et al.  Post-translational regulation of the 54K cellular tumor antigen in normal and transformed cells , 1981, Molecular and cellular biology.

[37]  T. Kanda,et al.  Human papillomavirus type 16 transformation of primary human embryonic fibroblasts requires expression of open reading frames E6 and E7 , 1989, Journal of virology.

[38]  D. Lane,et al.  T antigen is bound to a host protein in SY40-transformed cells , 1979, Nature.

[39]  E. Appella,et al.  Wild type human p53 is antiproliferative in SV40-transformed hamster cells. , 1990, Oncogene.

[40]  E. Harlow,et al.  Cellular targets for transformation by the adenovirus E1A proteins , 1989, Cell.

[41]  K. Münger,et al.  The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. , 1989, Science.

[42]  R. Schlegel,et al.  The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes , 1989, Journal of virology.

[43]  V. Rotter,et al.  Reconstitution of p53 expression in a nonproducer Ab-MuLV-transformed cell line by transfection of a functional p53 gene , 1984, Cell.

[44]  E. Androphy,et al.  Transcriptional activation by the papillomavirus E6 zinc finger oncoprotein. , 1990, The EMBO journal.

[45]  Rotter,et al.  Meth A fibrosarcoma cells express two transforming mutant p53 species. , 1988, Oncogene.

[46]  T. Noda,et al.  Identification of a transforming gene of human papillomavirus type 16 , 1989, Journal of virology.

[47]  D. Ledbetter,et al.  Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. , 1989, Science.

[48]  T. Kanda,et al.  Immortalization of primary rat cells by human papillomavirus type 16 subgenomic DNA fragments controlled by the SV40 promoter. , 1988, Virology.

[49]  V. Rotter,et al.  Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation , 1984, Nature.

[50]  F. Wettstein,et al.  Transcription of human papillomavirus type 16 early genes in a cervical cancer and a cancer-derived cell line and identification of the E7 protein. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[51]  A. Levine,et al.  Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells , 1982, Cell.

[52]  A. Levine,et al.  Association of human papillomavirus types 16 and 18 E6 proteins with p53. , 1990, Science.

[53]  S. Grossman,et al.  Inducible and constitutive enhancer domains in the noncoding region of human papillomavirus type 18 , 1988, Journal of virology.

[54]  G. Lozano,et al.  Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene. , 1990, Science.